| |
Impact of Patient-Related Factors on the Pharmacokinetics of Bulevirtide
|
| |
| |
EASL 2022 June 22-26 London
Renu Singh,1 Parag Kumar,1 Rory Leisegeng,1 Francesco Bellanti,2 Craig Comisar,2 Kishore Polireddy,2 Vithika Suri,1 Dmitry Manuilov,1 John Flaherty,1 Sandhya Girish1
1Gilead Sciences, Inc., Foster City, California, USA; 2Certara Netherlands B.V., Amsterdam, the Netherlands
|
|
| |
| |
|
|
|
